Article
Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection.
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
The Journal of Immunology (impact factor:
5.79).
06/2011;
186(12):6830-8.
DOI:10.4049/jimmunol.1001049
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
acute rejection
adoptive transfer model
allograft effector mechanisms
CXCR3-deficient CD8(+)
dramatic reduction
effective therapy
effector T lymphocytes
end-stage pulmonary diseases
fatal pulmonary inflammation
frequent complication
lung rejection
Lung transplantation
lungs
modulating chemokine activity
target organ
Teff
tolerized CXCR3-deficient Teff
transplant tolerance
transplantation tolerance
wild-type Teff